Thus, early studies from Dr. Wolf’s laboratory showed that, although increased FGF23 levels may prevent hyperphosphatemia, they caused an over-suppression of active vitamin D synthesis, which could have detrimental consequences [23]. The gene discussed is FGF23; the disease is hyperphosphatemia.